Navellier & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-135,582
| Closed | -$4.24M | – | 287 |
|
|
2016
Q4 | $4.24M | Sell |
135,582
-161,736
| -54% | -$5.05M | 0.7% | 59 |
|
|
2016
Q3 | $11.9M | Buy |
297,318
+167,178
| +128% | +$6.72M | 1.71% | 8 |
|
|
2016
Q2 | $4.33M | Buy |
130,140
+40,938
| +46% | +$1.36M | 0.65% | 49 |
|
|
2016
Q1 | $2.62M | Buy |
89,202
+37,317
| +72% | +$1.1M | 0.34% | 55 |
|
|
2015
Q4 | $1.37M | Sell |
51,885
-5,055
| -9% | -$133K | 0.15% | 66 |
|
|
2015
Q3 | $1.35M | Sell |
56,940
-96
| -0.2% | -$2.27K | 0.14% | 74 |
|
|
2015
Q2 | $1.35M | Buy |
57,036
+12,948
| +29% | +$307K | 0.12% | 96 |
|
|
2015
Q1 | $1.05M | Buy |
44,088
+11,370
| +35% | +$270K | 0.09% | 109 |
|
|
2014
Q4 | $695K | Buy |
+32,718
| New | +$695K | 0.03% | 146 |
|